Key result
US permanent pacemaker use rose ~56% from 1993 to 2009, dominated by dual-chamber devices.
Why the study?
Contemporary trends in permanent pacemaker use in the United States have not been well defined since the Medicare National Coverage Determination has remained unchanged since 1985.
Observational (n=2,900,000)
Yes
Answers are grounded in this paper and cite their sources.
Permanent pacemaker implantation in the US increased by 55.6% from 1993 to 2009, driven by a significant shift toward dual-chamber devices despite older and more comorbid patient populations.
OBJECTIVES: This study sought to define contemporary trends in permanent pacemaker use by analyzing a large national database. BACKGROUND: The Medicare National Coverage Determination for permanent pacemaker, which emphasized single-chamber pacing, has not changed significantly since 1985. We sought to define contemporary trends in permanent pacemaker use by analyzing a large national database. METHODS: We queried the Nationwide Inpatient Sample to identify permanent pacemaker implants between 1993 and 2009 using the International Classification of Diseases-Ninth Revision-Clinical Modification procedure codes for dual-chamber (DDD), single-ventricular (VVI), single-atrial (AAI), or biventricular (BiV) devices. Annual permanent pacemaker implantation rates and patient demographics were analyzed. RESULTS: Between 1993 and 2009, 2.9 million patients received permanent pacemakers in the United States. Overall use increased by 55.6%. By 2009, DDD use increased from 62% to 82% (p < 0.001), whereas single-chamber ventricular pacemaker use fell from 36% to 14% (p = 0.01). Use of DDD devices was higher in urban, nonteaching hospitals (79%) compared with urban teaching hospitals (76%) and rural hospitals (72%). Patients with private insurance (83%) more commonly received DDD devices than Medicaid (79%) or Medicare (75%) recipients (p < 0.001). Patient age and Charlson comorbidity index increased over time. Hospital charges ($2011) increased 45.3%, driven by the increased cost of DDD devices. CONCLUSIONS: There is a steady growth in the use of permanent pacemakers in the United States. Although DDD device use is increasing, whereas single-chamber ventricular pacemaker use is decreasing. Patients are becoming older and have more medical comorbidities. These trends have important health care policy implications.
No takes yet. Share an insight, caveat, or question.
Greenspon et al. (2012) conducted an observational in Permanent pacemaker implantation (n=2,900,000). Time period (2009 vs 1993) vs. 1993 was evaluated on Dual-chamber (DDD) pacemaker use (p=<0.001). Between 1993 and 2009, overall permanent pacemaker use in the US increased by 55.6%, with dual-chamber device use increasing from 62% to 82% and single-ventricular use falling to 14%.
Synapse has enriched 10 related papers. Consider them for comparative context: